Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2017 (pdf):
download in single page format - double page (broad) format

Publication overview

Current news and events

Maria Torgersen and coworkers publish unexpected results about nanoparticle effects on cells

Maria Torgersen, senior author

The article entitled “Small variations in nanoparticle structure dictate differential cellular stress responses and mode of cell death”, just published in Nanotoxicology, describes details about the toxic mechanisms obtained by testing three very similar nanoparticles on six cancer cell lines. The three different types of particles where all of the class poly(alkylcyanoacrylate), they differed only in their alkyl side chains being butyl (PBCA), ethylbutyl (PEBCA) or octyl (POCA). Such substances have for many years been used as medical glue. The authors describe different effects of these nanoparticles.

Computer simulated cancer treatment presented in research magazine Apollo

Arnoldo Frigessi (photo: Ola Sæther)

Researchers at the Oslo University Hospital and University of Oslo are developing a computer program that can assist oncologists to find the best personalized treatment for each patient. The main driving force behind the project is Arnoldo Frigessi, professor in medical statistics at UiO, who is head of the "Oslo Centre for Biostatistics Epidemiology" at OUS and leader of the "Centre for Research-based Innovation" (SFI) "Big Insight".

The award winning research magazine "Apollon" recently presented the work of Frigessi and collaborators in an extensive feature article by Yngve Vogt.

Nature Communications publication:How Natural Killer Cells Remember their Education

Karl-Johan Malmberg,
Senior author

A joint effort by several groups at the Institute for Cancer Research and University of Oslo, led by Dr. Jodie Goodridge and Prof. Karl-Johan Malmberg provide new insights into the molecular basis behind NK cell education.

NK cells calibrate their functional potential against host MHC in a process termed education. Paradoxically, the more inhibitory input the cell receives during its education, the stronger its functional potential. Although this phenomena is well documented and conserved across species, the cellular and molecular mechanisms underlying NK cell education have remained elusive. 

Units and subpages

View all subunitsHide all subunits